Status:
COMPLETED
Effects of a Female Hormone Balance Supplement on Symptoms of Polycystic Ovary Syndrome and Severe Premenstrual Syndrome
Lead Sponsor:
Rael
Collaborating Sponsors:
Citruslabs
Conditions:
Polycystic Ovary Syndrome
Premenstrual Syndrome
Eligibility:
FEMALE
18-55 years
Phase:
NA
Brief Summary
This is a virtual single group study that will last 12 weeks. Participants will take 1 scoop of the female hormone balance supplement, and mix it with their drink of choice every morning. Questionnair...
Eligibility Criteria
Inclusion
- Women aged between 18 - 55
- BMI less than 35
- Self-reported concerns around irregular menstrual cycles and ovulation, mood swings, stress, irritability, and low energy
- Generally healthy - don't live with any uncontrolled chronic disease
- Self-reported symptoms of PCOS - irregular periods
- Self-reported concerns with hormonal skin issues
Exclusion
- Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders
- Anyone with known severe allergic reactions
- Anyone who is pregnant, breastfeeding, or attempting to become pregnant
- Unwilling to follow the study protocol
Key Trial Info
Start Date :
August 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 19 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06124300
Start Date
August 30 2023
End Date
January 19 2024
Last Update
August 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Citruslabs
Santa Monica, California, United States, 90404